Follow-Up Care for Breast and Colorectal Cancer Across the Globe: Survey Findings From 27 Countries.

Autor:	Mollica MA; National Cancer Institute Bethesda, MD., Mayer DK; University of North Carolina at Chapel Hill, Chapel Hill, NC., Oeffinger KC; Duke University School of Medicine, Durham, NC., Kim Y; University of Miami, Coral Gables, FL., Buckenmaier SS; National Cancer Institute Bethesda, MD., Sivaram S; National Cancer Institute Bethesda, MD., Muha C; National Cancer Institute Bethesda, MD., Taib NA; Graddip Genet Counsell, University of Malaya, Kuala Lumpur, Malaysia., Andritsch E; Medizinische Universitat Graz, Graz, Austria., Asuzu CC; University of Ibadan, Ibadan, Nigeria., Bochis OV; Universitatea de Medicina si Farmacie Iuliu Hatieganu Facultatea de Medicina, Cluj-Napoca, Romania., Diaz S; Universidad Autonoma de Santo Domingo Facultad Ciencias de la Salud, Santo Domingo, Dominican Republic., Trill MD; Hospital General Universitario Gregorio Maranon, Madrid, Spain., Garcia PJ; Universidad Peruana Cayetano Heredia, Lima, Peru., Grassi L; University of Ferrara, Ferrara, Italy., Uchitomi Y; National Cancer Center Hospital, Tokyo, Japan., Shaikh AJ; Aga Khan University, Karachi, Pakistan., Jefford M; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Lee HJ; National Cancer Center, Goyang, Korea., Johansen C; Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Luyirika E; African Palliative Care Association, Kampala, Uganda., Maher EJ; Macmillan Cancer Support, London, United Kingdom., Mallillin MMB; Asian Hospital and Medical Center, Muntinlupa, Philippines., Maniragaba T; Republic of Rwanda Ministry of Health, Kigali, Rwanda., Mehnert-Theuerkauf A; Universitat Medical Center Leipzig, Leipzig, Germany., Pramesh CS; Tata Memorial Centre, Mumbai, India., Siesling S; Netherlands Comprehensive Cancer Organisation and University of Twente, Enschede, the Netherlands., Spira O; Israel Cancer Association, Givatayim, Israel., Sussman J; McMaster University, Hamilton, Ontario, Canada., Tang L; Peking University Cancer Hospital, Beijing, People's Republic of China., Hai NV; Ho Chi Minh City University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam., Yalcin S; Hacettepe University Institute of Cancer, Ankara, Turkey., Jacobsen PB; National Cancer Institute Bethesda, MD.
Jazyk:	angličtina
Zdroj:	JCO global oncology [JCO Glob Oncol] 2020 Sep; Vol. 6, pp. 1394-1411.
DOI:	10.1200/GO.20.00180
Abstrakt:	Purpose: The purpose of this study was to describe follow-up care for breast and colorectal cancer survivors in countries with varying levels of resources and highlight challenges regarding posttreatment survivorship care. Methods: We surveyed one key stakeholder from each of 27 countries with expertise in survivorship care on questions including the components/structure of follow-up care, delivery of treatment summaries and survivorship care plans, and involvement of primary care in survivorship. Descriptive analyses were performed to characterize results across countries and variations between the WHO income categories (low, middle, high). We also performed a qualitative content analysis of narratives related to survivorship care challenges to identify major themes. Results: Seven low- or /lower-middle-income countries (LIC/LMIC), seven upper-middle-income countries (UMIC), and 13 high-income countries (HICs) were included in this study. Results indicate that 44.4% of countries with a National Cancer Control Plan currently address survivorship care. Additional findings indicate that HICs use guidelines more often than those in LICs/LMICs and UMICs. There was great variation among countries regardless of income level. Common challenges include issues with workforce, communication and care coordination, distance/transportation issues, psychosocial support, and lack of focus on follow-up care. Conclusion: This information can guide researchers, providers, and policy makers in efforts to improve the quality of survivorship care on a national and global basis. As the number of cancer survivors increases globally, countries will need to prioritize their long-term needs. Future efforts should focus on efforts to bridge oncology and primary care, building international partnerships, and implementation of guidelines.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu